Literature DB >> 32801227

Authors' response.

Pranab Chatterjee1, Tanu Anand2, Kh Jitenkumar Singh3, Reeta Rasaily4, Ravinder Singh5, Santasabuj Das6, Harpreet Singh7, Ira Praharaj8, Raman R Gangakhedkar8, Balram Bhargava9, Samiran Panda10.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32801227      PMCID: PMC7853257          DOI: 10.4103/0971-5916.292093

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


× No keyword cloud information.
We thank the authors for a close reading of our article1. Given the known biases in recruiting study participants for a case-control study, we decided to choose symptomatic HCWs who were tested for SARS-CoV-2 infection to maintain evenness in the way cases and controls were selected. We would like to posit that the reasons for which asymptomatic HCWs got tested were likely to be different from those of symptomatic HCWs. Hence, to maintain comparability between the cases and controls, we decided to include only symptomatic HCWs. We tried to adhere to the basic tenets of case-control investigations - the cases and controls should be comparable, except in that the case group experienced the outcome of interest. In addition, we would like to add that an analysis of one million tests conducted in India between January and April 2020 has shown that about 28 per cent of SARS-CoV-2-positive patients are asymptomatic2. The standard practice in developing logistic regression models begins with the selection of independent variables using multiple strategies - known or established theories, existing evidence, exploratory analyses or a combination of these and other strategies3. The purpose of the univariate analysis was to identify the variables that were more likely to be statistically and biologically associated with the outcome of interest. To construct a parsimonious model, we chose to include biologically plausible variables which met a cut-off value (P<0.1). This is clarified in the subsection titled ‘multivariate analysis'. Further, we would like to emphasize that it is important to limit the number of independent variables to avoid a mathematically unstable model with limited generalizability beyond the current data4. In order for readers to appreciate the process, and to declare the associations observed through the univariate analyses, we chose to present both analyses. While we acknowledge the lower response rate, this is a known shortcoming of telephone-based surveys. While in-person interviewing remains the method providing the highest yield in terms of response efficiency and representativeness, it was an untenable strategy given the realities of the ongoing pandemic and restrictions imposed on the movement of people by the nationwide lockdown. Also noteworthy is that, compared to online, mail, or self-reported data collection, telephone-based surveys provide better representativeness, more complete data and higher data yield56. To improve the response rate, we employed different strategies such as training of interviewers and multiple call attempts at different times of the day. Further, our study received higher response rates than similar methodologies employed to cover HCWs in India (paediatricians: 57%)7 and abroad (Germany: physicians, 56%8; France: physicians, 59%9 and USA: internists, 64%10). The study participants were asked to declare the side effects experienced by them in our investigation. As noted in the ‘Results’ section, a very small proportion of the participants self-reported adverse effects linked to HCQ intake, and the frequency of occurrence of side effects was not significantly different across the case and control groups1.
  6 in total

1.  Doctors' opinions on euthanasia, end of life care, and doctor-patient communication: telephone survey in France.

Authors:  P Peretti-Watel; M K Bendiane; H Pegliasco; J M Lapiana; R Favre; A Galinier; J P Moatti
Journal:  BMJ       Date:  2003-09-13

2.  Logistic regression: a brief primer.

Authors:  Jill C Stoltzfus
Journal:  Acad Emerg Med       Date:  2011-10       Impact factor: 3.451

3.  A national survey of U.S. internists' experiences with ethical dilemmas and ethics consultation.

Authors:  Gordon DuVal; Brian Clarridge; Gary Gensler; Marion Danis
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

4.  Subjective Reasons for Non-Reporting of Adverse Drug Reactions in a Sample of Physicians in Outpatient Care.

Authors:  M Gahr; J Eller; B J Connemann; C Schönfeldt-Lecuona
Journal:  Pharmacopsychiatry       Date:  2016-01-07       Impact factor: 5.788

5.  Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.

Authors:  Pranab Chatterjee; Tanu Anand; Kh Jitenkumar Singh; Reeta Rasaily; Ravinder Singh; Santasabuj Das; Harpreet Singh; Ira Praharaj; Raman R Gangakhedkar; Balram Bhargava; Samiran Panda
Journal:  Indian J Med Res       Date:  2020-05       Impact factor: 2.375

6.  Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.

Authors: 
Journal:  Indian J Med Res       Date:  2020-05       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.